BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36057223)

  • 1. Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8
    Chang Z; Zhang Q; Hu Q; Liu Y; Zhang L; Liu R
    Biomed Pharmacother; 2022 Oct; 154():113543. PubMed ID: 36057223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
    Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
    Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
    Song Z; Wang X; Liu X; Luo Y; Qiu J; Yin A; Liu Y; Yi H; Xiao Z; Li A
    Biochem Pharmacol; 2023 Jul; 213():115612. PubMed ID: 37209858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.
    Li Y; Chen Y; Zhao C; Yang Y; Zhang M; Cheng H; Li Q; Wang M
    Phytomedicine; 2024 Jun; 128():155532. PubMed ID: 38493722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
    ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/STAT3 inhibited CD8
    Wang C; Shen N; Guo Q; Tan X; He S
    Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
    Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
    Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
    Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z
    Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization.
    Wang M; Li Y; Li S; Wang T; Wang M; Wu H; Zhang M; Luo S; Zhao C; Li Q; Cheng H
    J Ethnopharmacol; 2024 Mar; 321():117472. PubMed ID: 37995825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
    Han S; Bao X; Zou Y; Wang L; Li Y; Yang L; Liao A; Zhang X; Jiang X; Liang D; Dai Y; Zheng QC; Yu Z; Guo J
    Sci Adv; 2023 Jul; 9(29):eadg2697. PubMed ID: 37467325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-κB signaling.
    Wen J; Yang S; Yan G; Lei J; Liu X; Zhang N; Zhang J; Deng H; Wu L; Li Y
    Exp Cell Res; 2023 Jul; 428(2):113651. PubMed ID: 37201744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
    Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
    J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.
    Wu H; Jiang N; Li J; Jin Q; Jin J; Guo J; Wei X; Wang X; Yao L; Meng D; Zhi X
    J Cell Physiol; 2024 Jan; 239(1):97-111. PubMed ID: 37921259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
    Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
    Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma.
    Chen F; Yang L; Peng X; Mao M; Liu X; Song J; Hu J
    Mol Immunol; 2022 Nov; 151():204-217. PubMed ID: 36179603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8
    Zhang X; Wei Z; Yong T; Li S; Bie N; Li J; Li X; Liu H; Xu H; Yan Y; Zhang B; Chen X; Yang X; Gan L
    Nat Commun; 2023 Sep; 14(1):5653. PubMed ID: 37704614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.